Nicole L. Yates

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial”.

Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial

Nature Medicine(2022)10.1038/s41591-022-01815-1

N/A

2.7DataRank · unranked

143 citations

Kathryn E. Stephenson, Kshitij Wagh, Sabrina C. Tan, Rebecca Zash, Stephen R. Walsh +32 more

Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial

Nature Medicine(2021)10.1038/s41591-021-01509-0

N/A

2.3DataRank · unranked

104 citations

Boris Jülg, Chen Sabrina Tan, Rebecca Zash, Stephen R. Walsh, Charlotte-Paige Rolle +35 more

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

PLoS Medicine(2020)10.1371/journal.pmed.1003038

N/A

1.2DataRank · unranked

48 citations

Zoe Moodie, Kristen W. Cohen, Nicole Grunenberg, Linda‐Gail Bekker, Mary Allen +26 more

Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac260

N/A

1.1DataRank · unranked

50 citations

One Dintwe, Sheetal Sawant, Doug Grove, Yunda Huang, Holly Janes +43 more

Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial

The Lancet HIV(2024)10.1016/s2352-3018(24)00247-9

N/A

0.381DataRank · unranked

11 citations

Christopher B. Hurt, Kathryn E. Stephenson, Yunda Huang, Carmen A. Paez, Chenchen Yu +95 more

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1–2 randomized double-blind placebo-controlled trial

PLOS Global Public Health(2024)10.1371/journal.pgph.0003319

N/A

0.108DataRank · unranked

1 citations

Fatima Laher, Linda‐Gail Bekker, Kelly E. Seaton, Mary Allen, Stephen De Rosa +27 more

Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans

npj Vaccines(2021)10.1038/s41541-021-00305-8

N/A

0DataRank · unranked

15 citations

Aaron Deal, Xue Han, Shuying S. Li, Ashley Clayton, Jack Heptinstall +25 more

Lower SARS-CoV-2–specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19

JCI Insight(2022)10.1172/jci.insight.158402

N/A

0DataRank · unranked

21 citations

Shelly Karuna, Caroline Brackett, Martina S. Wesley, Shuying S. Li, Nathan Eisel +20 more

Broadly binding and functional antibodies and persisting memory B cells elicited by HIV vaccine PDPHV

npj Vaccines(2022)10.1038/s41541-022-00441-9

N/A

0DataRank · unranked

10 citations

Nicole L. Yates, Justin Pollara, Yegor Voronin, Sherry Stanfield-Oakley, Dong Han +6 more

Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges

Frontiers in Immunology(2022)10.3389/fimmu.2022.788619

N/A

0DataRank · unranked

9 citations

Mario Amacker, Dinesh Hariraju, Hemant K. Vyas, Kyle S. Morrison, Joshua A. Weiner +12 more

Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study

Frontiers in Immunology(2022)10.3389/fimmu.2022.939627

N/A

0DataRank · unranked

3 citations

Benedikt Asbach, Carmen Gómez, Josef Köstler, Susan W. Barnett, Marguerite Koutsoukos +19 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

EBioMedicine(2023)10.1016/j.ebiom.2023.104590

N/A

0DataRank · unranked

33 citations

Yunda Huang, Shelly Karuna, Jack Heptinstall, Caroline Brackett, Kelvin Chiong +40 more

Computational analysis of antibody dynamics identifies recent HIV-1 infection

UNC Libraries(2023)10.17615/x3bs-f172

N/A

0DataRank · unranked

0 citations

G.D. Tomaras, N.A. Vandergrift, T.N. Denny, Ann Duerr, H.-X. Liao +23 more

Precise targeting of HIV broadly neutralizing antibody precursors in humans

Science(2025)10.1126/science.adv5572

N/A

0DataRank · unranked

43 citations

Madhu Prabhakaran, Gabriel Ozorowski, Kellie J. MacPhee, Weiwei Wu, Karlijn van der Straten +71 more

A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses

Vaccines(2025)10.3390/vaccines13020133

N/A

0DataRank · unranked

3 citations

Bette Korber, Rachel L. Spreng, Sheetal Sawant, Allan C. deCamp, Arthur S. McMillan +12 more

Distinct immune responses in people living with HIV following SARS-CoV-2 recovery

Communications Medicine(2025)10.1038/s43856-025-00839-1

N/A

0DataRank · unranked

1 citations

Shuying Sue Li, Daniel J. Schuster, Xiaohong Li, Jiani Hu, Shelly Karuna +24 more

3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope–specific plasma cells and humoral immunity in nonhuman primates

Science Immunology(2020)10.1126/sciimmunol.abb1025

N/A

0DataRank · unranked

152 citations

Mohammed Ata Ur Rasheed, Colin Havenar‐Daughton, Mathew Pham, Traci Legere, Zarpheen Jinnah Sher +25 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

UNC Libraries(2025)10.17615/19xw-z883

N/A

0DataRank · unranked

0 citations

José A. Hidalgo, Fatima Laher, John Hural, Nicole L. Yates, Caroline Brackett +40 more

HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens

Scientific Reports(2020)10.1038/s41598-020-57491-z

N/A

0DataRank · unranked

24 citations

Fatima Laher, Zoe Moodie, Arthur S. McMillan, Rachel L. Spreng, Peter B. Gilbert +15 more

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

PLoS Medicine(2020)10.1371/journal.pmed.1003117

N/A

0DataRank · unranked

14 citations

Stephen R. Walsh, Fatima Laher, Lucas Maganga, Michael E. Herce, Sarita Naidoo +28 more

Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection

DukeSpace (Duke University)(2020)10.17615/0r8q-w086

N/A

0DataRank · unranked

4 citations

Tracy L. Nolen, Thomas N. Denny, Nicole L. Yates, Georgia D. Tomaras, Barton F. Haynes +5 more

The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination

Nature Immunology(2021)10.1038/s41590-021-01026-9

N/A

0DataRank · unranked

25 citations

Adam Pelletier, Slim Fourati, Muhammad Latif, Ashish Sharma, Kathryn L. Furr +18 more

Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS

Frontiers in Immunology(2021)10.3389/fimmu.2021.709994

N/A

0DataRank · unranked

17 citations

Kelvin Chiong, Kelly E. Seaton, Christine A. Arocena, Sheetal Sawant, Jonathan Hare +11 more